Cardio Diagnostics holds annual shareholder meeting

• Cardio Diagnostics Holdings held its annual shareholder meeting on September 18, 2026.
• Shareholders elected seven directors to serve until the next annual meeting.
• Investors authorized potential future non-public issuance of common stock or convertible or exercisable securities equal to 20% or more outstanding.
• Prager Metis CPA's LLC was ratified as independent registered public accounting firm for the fiscal year ending December 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardio Diagnostics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001553350-26-000131), on September 18, 2026, and is solely responsible for the information contained therein.